Beacon Pointe Advisors LLC Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Beacon Pointe Advisors LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 48.8% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 6,185 shares of the medical equipment provider’s stock after acquiring an additional 2,029 shares during the period. Beacon Pointe Advisors LLC’s holdings in Intuitive Surgical were worth $3,361,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Wellspring Financial Advisors LLC purchased a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $292,000. Quantbot Technologies LP increased its stake in Intuitive Surgical by 46.6% during the 2nd quarter. Quantbot Technologies LP now owns 40,485 shares of the medical equipment provider’s stock valued at $22,000,000 after purchasing an additional 12,872 shares in the last quarter. Portfolio Design Labs LLC raised its holdings in shares of Intuitive Surgical by 39.8% in the second quarter. Portfolio Design Labs LLC now owns 1,920 shares of the medical equipment provider’s stock worth $1,043,000 after buying an additional 547 shares during the last quarter. Willis Johnson & Associates Inc. acquired a new stake in shares of Intuitive Surgical during the second quarter worth $224,000. Finally, Claret Asset Management Corp grew its holdings in shares of Intuitive Surgical by 4.8% during the second quarter. Claret Asset Management Corp now owns 5,969 shares of the medical equipment provider’s stock valued at $3,244,000 after buying an additional 275 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total value of $2,012,500.00. Following the sale, the executive vice president owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 28,800 shares of the business’s stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the completion of the sale, the insider directly owned 27,027 shares of the company’s stock, valued at approximately $14,798,904.12. The trade was a 51.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 108,939 shares of company stock worth $60,757,995. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Down 0.2%

Shares of Intuitive Surgical stock opened at $568.63 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The business has a 50-day moving average price of $515.92 and a 200 day moving average price of $505.59. The firm has a market cap of $203.84 billion, a PE ratio of 75.22, a P/E/G ratio of 5.24 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the business posted $1.84 earnings per share. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. Raymond James Financial set a $603.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Robert W. Baird set a $655.00 price objective on Intuitive Surgical in a report on Wednesday, October 22nd. Argus raised their price objective on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. BTIG Research upped their target price on Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Mizuho set a $575.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $607.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.